The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients

  • Michael J. Kelly-Sell, Youn H. Kim, Suzanne Straus, Bernice Benoit, Cameron Harrison, Katherine Sutherland, Randall Armstrong, Wen-Kai Weng, Louise C. Showe, Maria Wysocka, Alain H. Rook
  • American Journal of Hematology, February 2012, Wiley
  • DOI: 10.1002/ajh.23112

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/ajh.23112

In partnership with:

Link to Wiley showcase